These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23257069)

  • 1. Vaccination against tuberculosis: how can we better BCG?
    Pitt JM; Blankley S; McShane H; O'Garra A
    Microb Pathog; 2013 May; 58():2-16. PubMed ID: 23257069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.
    Aguilo N; Toledo AM; Lopez-Roman EM; Perez-Herran E; Gormley E; Rullas-Trincado J; Angulo-Barturen I; Martin C
    Clin Vaccine Immunol; 2014 Apr; 21(4):594-7. PubMed ID: 24501340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG-induced protection: effects on innate immune memory.
    Netea MG; van Crevel R
    Semin Immunol; 2014 Dec; 26(6):512-7. PubMed ID: 25444548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Humoral Immune Response to BCG Vaccination.
    Tanner R; Villarreal-Ramos B; Vordermeier HM; McShane H
    Front Immunol; 2019; 10():1317. PubMed ID: 31244856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.
    Ordway DJ; Shang S; Henao-Tamayo M; Obregon-Henao A; Nold L; Caraway M; Shanley CA; Basaraba RJ; Duncan CG; Orme IM
    Clin Vaccine Immunol; 2011 Sep; 18(9):1527-35. PubMed ID: 21795460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.
    Castillo-Rodal AI; Castañón-Arreola M; Hernández-Pando R; Calva JJ; Sada-Díaz E; López-Vidal Y
    Infect Immun; 2006 Mar; 74(3):1718-24. PubMed ID: 16495544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.
    Festjens N; Bogaert P; Batni A; Houthuys E; Plets E; Vanderschaeghe D; Laukens B; Asselbergh B; Parthoens E; De Rycke R; Willart MA; Jacques P; Elewaut D; Brouckaert P; Lambrecht BN; Huygen K; Callewaert N
    EMBO Mol Med; 2011 Apr; 3(4):222-34. PubMed ID: 21328541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B.
    Gillis TP; Tullius MV; Horwitz MA
    Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
    Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
    Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice.
    Jeon BY; Derrick SC; Lim J; Kolibab K; Dheenadhayalan V; Yang AL; Kreiswirth B; Morris SL
    Infect Immun; 2008 Nov; 76(11):5173-80. PubMed ID: 18710860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
    Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
    Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of live recombinant vaccine candidates against tuberculosis.
    Hess J; Kaufmann SH
    Scand J Infect Dis; 2001; 33(10):723-4. PubMed ID: 11728033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.
    Keyser A; Troudt JM; Taylor JL; Izzo AA
    Vaccine; 2011 Nov; 29(50):9308-15. PubMed ID: 22015391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.